BioCentury | Aug 4, 2020
Politics, Policy & Law

China doubling size of centralized procurement program

...set a 70% market share ceiling for eight antibiotics slated for inclusion in the program: ciprofloxacin...
BioCentury | Apr 1, 2020
Distillery Therapeutics

Targeting curli amyloid fiber subunits csgA and csgB to treat Salmonella

...the number of bacteria that dissociated from the biofilm. The mAb plus generic antibiotics ampicillin, ciprofloxacin...
BioCentury | Sep 12, 2019
Preclinical News

Sept. 12 Preclinical Quick Takes: Stephen Quake newco reveals epigenomic platform; plus Personal Genome, Summit and Biolife4D

...burden in mouse models of sepsis, pneumonia and urinary tract infection comparable to tigecycline and ciprofloxacin...
BioCentury | Jul 25, 2019
Distillery Therapeutics

Phenylisoxazole-quinoline-based DNA gyrase inhibitor for drug-resistant

...85 nM and inhibited growth of five S. aureus strains resistant to the generic antibiotics ciprofloxacin...
BioCentury | Apr 6, 2018
Finance

Fundamentally driven

...Symdeko Company Setback Aradigm Corp. (NASDAQ:ARDM) FDA issues a complete response letter for Linhaliq liposomal ciprofloxacin...
BioCentury | Apr 6, 2018
Clinical News

Aradigm's Linhaliq under EMA review for lung infection

...Aradigm Corp. (NASDAQ:ARDM) said EMA accepted for review an MAA for Linhaliq liposomal ciprofloxacin to treat...
...a liposomal-encapsulated form of ciprofloxacin, a DNA gyrase inhibitor, mixed with a solution of free ciprofloxacin...
...Grifols S.A. (Madrid:GRF; NASDAQ:GRFS), Barcelona, Spain Product: Linhaliq liposomal ciprofloxacin Business: Infectious disease Jennie Walters Linhaliq, liposomal ciprofloxacin...
BioCentury | Apr 5, 2018
Company News

Aradigm's Linhaliq under EMA review for lung infection

...Aradigm Corp. (NASDAQ:ARDM) said EMA accepted for review an MAA for Linhaliq liposomal ciprofloxacin to treat...
...a liposomal-encapsulated form of ciprofloxacin, a DNA gyrase inhibitor, mixed with a solution of free ciprofloxacin...
...climbed €0.80 to €22.87 in Madrid, but lost $0.10 to $20.48 on NASDAQ. Jennie Walters Linhaliq, liposomal ciprofloxacin...
BioCentury | Apr 3, 2018
Distillery Therapeutics

Infectious disease

...MRSA for 100 days, the two retinoids induced less drug resistance than the generic antibiotic ciprofloxacin...
BioCentury | Mar 28, 2018
Preclinical News

Brown researchers suggest retinoids as anti-MRSA antibiotic

...In liquid culture, MRSA developed less resistance to CD437 or CD1530 than the generic antibiotic ciprofloxacin...
BioCentury | Mar 16, 2018
Clinical News

FDA approves label expansion for Otonomy's Otiprio

...Otonomy Inc. (NASDAQ:OTIC) said FDA approved an sNDA for Otiprio ciprofloxacin to treat acute otitis externa...
...infection in patients ages six months and older. Otiprio is a sustained-release gel formulation of ciprofloxacin...
...media with effusion undergoing tympanostomy tube placement. Otonomy Inc. (NASDAQ:OTIC), San Diego, Calif. Product: Otiprio ciprofloxacin...
Items per page:
1 - 10 of 291